Peregrine Pharmaceuticals reported $953.6M in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 0.64B 0.19B
Amgen AMGN:US $ 129.08B 2.36B
AstraZeneca AZN:LN 156.99B 22.53B
Biocryst Pharmaceuticals BCRX:US $ 3B 0.51B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Celldex Therapeutics CLDX:US $ 1.59B 0.21B
Chemocentryx CCXI:US $ 1.78B 0.78B
Eli Lilly And LLY:US $ 272.72B 8.49B
GlaxoSmithKline GSK:LN 83.74B 2.9B
Immunogen IMGN:US $ 1.05B 0.54B
Intrexon XON:US $ 0.44B 0.33B
Karyopharm Therapeutics KPTI:US $ 0.58B 0.1B
Macrogenics MGNX:US $ 0.54B 0.44B
Mannkind MNKD:US $ 0.93B 0.17B
Merk MRK:US $ 207.45B 13.86B
Minerva Neurosciences NERV:US $ 0.04B 0B
Newlink Genetics NLNK:US $ 0.08B 0.02B
Novartis NOVN:VX 197.8B 2.36B
Novavax NVAX:US $ 5.62B 5.2B
Peregrine Pharmaceuticals PPHM:US $ 1.8B 0.47B
Repligen RGEN:US $ 10.41B 4.24B
Roche Holding ROG:VX 300.5B 1.25B
Xencor XNCR:US $ 1.58B 0.76B